Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

NOTE’s Nomination Committee for the Annual General Meeting 2017

According to the decision by the Annual General Meeting (AGM), the members of the Nomination Committee should be appointed by the four shareholders having the largest holdings in NOTE and which desire to appoint a representative. The Nomination Committee consists of:- Bruce Grant, Garden Growth Capital LLC- Johan Hagberg, own holdings- Jonas Hagströmer, Creades AB- Peter Svanlund, Banque Carnegie Luxembourg S.A. (on behalf of Museion Förvaltning AB) The Nomination Committee is appointed by shareholders together representing approximately 42 percent of the voting rights for all

Cantargia to present new data from preclinical studies with CAN04 in non-small cell lung cancer

Cantargia AB (“Cantargia”) will be presenting new data at the Protein & Antibody Engineering Summit (“PEGS ”), an international scientific conference to be held in Lisbon, Portugal, from October 31st to November 4th 2016. The company will be presenting data from preclinical studies in non-small cell lung cancer, where the product candidate CAN04, a humanised antibody against the IL1RAP target molecule, has been investigated. The presentation will take place on October 31st 2016.With the ambition of developing a new cancer therapy, Cantargia has developed a

Hansa Medical proposes a directed share issue

· The board of directors of Hansa Medical AB (publ) (“Hansa Medical” or the “Company”) proposes a directed share issue of approximately SEK 185 million. · The subscription price for the issue is proposed to be SEK 70 per share. · The issue is directed to selected international specialist investors including HBM Healthcare Investments, Sectoral Asset Management, Sphera Funds Management and Aescap, as well as Swedish institutional and strategic investors including Carnegie Asset Management,AFA Insurance, KK-stiftelsen, Thomas Olausson and Unionen. · Shareholders representing

Notice of Extraordinary General Meeting of Hansa Medical AB (publ)

The shareholders of Hansa Medical AB (publ) are summoned to attend the Extraordinary General Meeting on 21 November 2016, at 10:30 am CET at Hansa Medical’s offices on Scheelevägen 22, Lund, Sweden.The shareholders of Hansa Medical AB (publ) are hereby summoned to attend the Extraordinary General Meeting (“EGM”) on 21 November 2016, at 10:30 am CET at Hansa Medical’s offices on Scheelevägen 22, Lund, Sweden. Registration starts at 10:00 am CET and will be possible until the meeting starts.  Right to participateThose who have been recorded as shareholders in the share register kept by

AQ Group AB (publ), Third quarter, 2016

Third quarter, July – September 2016In brief · Continued growth in sales and results, mainly driven by acquisitions · Net sales increased by 10 % to SEK 723 million (655) · Operating profit (EBIT) increased by 36 % to SEK 53 million (39) · Profit after financial items (EBT) increased by 20 % to SEK 53 million (44) · Cash flow from operating activities increased by 20 % to SEK 67 million (56) · Equity ratio 64 % (62) · Earnings per share after tax increased by 32 % to SEK 2.58 (1.95) Nine months, January – September 2016 In brief · Net sales increased by 12 %

Vitec Software Group AB: Vitec Interim report January - September 2016

NEGATIVE CURRENCY EFFECT BUT STRONGER CASH FLOW SUMMARY FOR JANUARY - SEPTEMBER 2016 · Net sales SEK 483 M (448) · Profit before tax SEK 57,6 M (67,8) · Operating margin 13,0 % (16,1) · Earnings per share before dilution SEK 1,56 (1,80) · Cash flow from operations SEK 123,8 M (105,8) SUMMARY FOR JULY - SEPTEMBER 2016 · Net sales SEK 164 M (152) · Profit before tax SEK 17,1 M (24,0) · Operating margin 11,8 % (16,8) · Earnings per share before dilution SEK 0,48 (0,65) · Cash flow from operations SEK 17,9 M (7,0) · Sales of Media and acquisitions of

Exercise of the over-allotment option

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR ANY OTHER JURISDICTION IN WHICH SUCH PUBLICATION, DISTRIBUTION OR RELEASE WOULD BE UNLAWFULABG Sundal Collier and Handelsbanken Capital Markets (“Joint Global Coordinators”) have notified Internationella Engelska Skolan i Sverige Holdings II AB (publ) (“IES” or the “Company”), Internationella Engelska Skolan i Sverige Holdings I AB (the ”Selling Shareholder”), a Company controlled by TA Associates, IES’ founder Barbara Bergström and parts of IES’ management and

Citycon’s Financial Reporting Schedule and AGM 2017

CITYCON OYJ   Stock Exchange Release   20 October 2016 at 9:05 hrsCitycon will release its full-year financial report as well as financial statements and the report by the Board of Directors for the period 1 January–31 December 2016 on Thursday, 9 February 2017 at about 9:00 a.m.Citycon Oyj’s Annual General Meeting 2017 will be held in Helsinki, Finland, on Wednesday, 22 March 2017 starting at 12:00 noon.Citycon will issue three interim reports during the financial year 2017 in accordance with the following schedule:                    January–March 2017 on Thursday, 20 April 2017 at

Increasing rental growth and rising values

Profit after tax for the period increased to SEK 4,346m (2,054), corresponding to earnings per share of SEK 26.28 (12.42). Profit before tax for the period rose to SEK 5,166m (2,637). Rental income amounted to SEK 1,573m (1,493) and net operating income to SEK 1,125m (1,080. In an identical portfolio, rental income rose by around 9 per cent and net operating income increased by roughly 10 per cent. The average yield requirement declined during the period to a rounded off figure of 4.70 per cent (4.94 at year-end).The effect of new lettings and renegotiations at good levels has gradually had

Citycon Q3: Successful opening of Iso Omena’s extension and bond issuance support earnings

Citycon Oyj   Stock Exchange Release   20 October 2016 at 09:00 hrsJULY—SEPTEMBER 2016- Gross rental income decreased to EUR 61.9 million (Q3/2015: 65.9) mainly due to the non-core property divestments in Finland and Sweden during 2015 and 2016, which decreased gross rental income by EUR 4.4 million. The divestments also decreased net rental income by EUR 3.9 million, while the Norwegian business unit (with the comparable exchange rates) and the opening of the first part of the Iso Omena extension increased net rental income by EUR 1.6 million.- EPRA Earnings decreased by EUR 0.3

Interim report Januari – September 2016

· Rental income increased to SEK 1,573m (1,493), primarily as a result of completed project properties generating revenue. In an identical portfolio, income rose by roughly 9 per cent (4). · Net operating income for the period increased to SEK 1,125m (1,080). In an identical portfolio, net operating income rose by approximately 10 per cent. The surplus ratio was 72 per cent (72). · Profit from property management rose by 23 per cent to SEK 637m (516). · Realised and unrealised changes in value amounted to SEK 4,660m (1,974) in properties and SEK –131m (111) in interest-rate

Mandatory notification of trades

Coldevin Invest AS, a company owned by Jørgen Pleym Ulvness, CEO in Obligo Holding AS and primary insider in Agasti Holding ASA, has on 19 October 2016 sold 6,963,538 shares in Agasti Holding ASA at a price of NOK 0.2508 per share. After this transaction, Pleym Ulvness owns and controls no shares in Agasti Holding ASA. Lokenmoen Invest AS, a company owned by Svein Erik Lilleland, Head of Corporate Finance in Obligo Investment Management AS and primary insider in Agasti Holding ASA, has on 19 October 2016 sold 1,822,917 shares in Agasti Holding ASA at a price of NOK 0.2878 per share.

Interim report January - September 2016

Kai Wärn, President and CEO:“The development for the seasonally slower third quarter was generally in line with expectations, with continued improvements in operating income and margin. Successful execution of efficiency measures continued to support earnings growth, offsetting unfavorable currency impact and at the same time creating headroom for investments in profitable growth initiatives in areas that will be key in the years to come. Operating income for the Group increased to SEK 431m (405) and the operating margin rose to 5.9% (5.5). Sales in the Husqvarna Division increased 5%

ASSA ABLOY acquires Trojan Holdings Limited in the United Kingdom

ASSA ABLOY has acquired Trojan Holdings Limited, a leading supplier of door and window hardware in the UK."I am very pleased to welcome Trojan into the ASSA ABLOY Group. Trojan offers a comprehensive portfolio of window and door hardware products that in a very good way complements the ASSA ABLOY offering in the UK market”, says Johan Molin, President and CEO of ASSA ABLOY. ”Trojan is an innovative, design driven business, with a strong management team and a great track record of growth and continuous product development”, says Tzachi Wiesenfeld, Executive Vice President of ASSA ABLOY

Strong finish of the financial year

Fourth quarter · Net sales for the quarter rose 11.0 per cent to SEK 1,952 million (1,759). · Organic growth in fixed exchange rates was 10.2 per cent (5.6). · The gross margin increased to 15.3 per cent (14.2). · Adjusted EBITA increased to SEK 81 million (67). · EBIT totalled SEK 65 million (46). · Items affecting comparability amounted to SEK - million (neg: 5). · Profit for the period totalled SEK 25 million (30). · Earnings per share, before and after dilution, including discontinued operations, amounted to SEK 0.33 (0.39). · Cash flow from operating

Interim report Jan-Sep: Positive operating profit and completing restructuring with impairment of a holding in Brazilian associated company

Third quarter · Order intake was 266.3 MSEK (309.0). · Net sales amounted to 271.1 MSEK (322.3). · Operating profit of 4.7 MSEK (12.0). · Profit/loss after tax was -72.7 MSEK (8.2) including 71.6 MSEK impairment of participations in associated company charged to profits. Excluding this impairment, profit/loss was -1.1 MSEK. · Earnings per share were -3.82 SEK (0.44). Nine months · Order intake amounted to 811.4 MSEK (989.5). · Net sales of 834.9 MSEK (1,041.6). · Operating profit/loss -46.6 MSEK (62.9). Profit was charged with non-recurring expenses of 50 MSEK

Axis AB: Interim report January-September 2016

Third quarter · Net sales increased by 5 percent during the third quarter to SEK 1,997 M (1,906). Net sales increased by 5 percent in local currencies. · Operating profit amounted to SEK 312 M (389), which corresponds to an operating margin of 15.6 percent (20.4). · Profit after tax amounted to SEK 233 M (289). · Earnings per share amounted to SEK 3.35 (4.16). January - September · Net sales increased by 9 percent during the period to SEK 5,327 M (4,876). Net sales increased by 10 percent in local currencies. · Operating profit amounted to SEK 632 M (650), which

Mycronic AB (publ), interim report January-September 2016

Nine months of strong order intake - execution of strategy for growthMycronic demonstrated a strong financial performance during the first nine months of the year. Order intake and net sales increased 44 and 9 percent respectively. The operating margin reached 22 percent. Demand for the Group’s products is favorable, thanks to product launches which broadened the Group’s addressable market. Mycronic also has major focus on investments for future growth, both through initiatives in product development and through acquisitions.Third quarter July-September 2016 · Order intake was SEK

Tobii’s CFO to Leave the Company

Tobii today announced that Esben Olesen has decided to leave Tobii after five years as Chief Financial Officer. Esben Olesen, part of Tobii's Group Management Team, has been employed since 2011. He will retain his responsibilities as CFO of Tobii until he leaves office in March 2017. The process of appointing a successor is under way. Esben Olesen will leave Tobii to take upon a similar position at another company. “Esben has played a significant role at Tobii, particularly before and during the company's IPO, and he has contributed to Tobii's success during these years. I will miss

Transcom: Interim report 1 January – 30 September 2016

Third quarter 2016 · Net revenue €143.7 million, a 5.3% decrease com-pared to Q3 2015 (151.8). Organic revenue decreased by 3.3%. · EBIT was €7.6 million (5.3), representing an EBIT margin of 5.3%, compared to 3.5% in Q3 2015 (4.0% excluding non-recurring items). · Net income €5.9 million (1.9). · Operating cash flow -€7.1 million (-9.4). · EPS 22.6 Euro cents (7.4). January-September 2016 · Net revenue €430.9 million (469.7), a decrease of 8.3%. Organic revenue decreased by 6.8%. · EBIT was €14.4 million (15.9), representing an EBIT margin of 3.3% (3.4%). EBIT

Interim Report January-September 2016

Strong Zubsolv® and Abstral® revenue growth. Third quarter 2016  · Total net revenues MSEK 181.9 (139.5).   · Zubsolv net revenue MSEK 142.8 (110.8). · Net earnings MSEK 36.0 (-46.1).  · Earnings per share, before and after dilution, SEK 1.04 (-1.33). · Cash flow from operating activities MSEK 31.2 (-79.5). · Cash and cash equivalents MSEK 276.9 (201.2).  · The US Department of Health and Human Services (HHS) announced an increase in buprenorphine patient cap from 100 to 275.  · The Congress signed CARA1into law which among others will expand the

Interim report for 1 January – 30 September 2016

Third quarter (1) ·  Net sales for continuing operations decreased by 1%, and amounted to SEK 917.1 (930.3) million  ·  Gross margin for continuing operations, excluding items affecting comparability, rose by 3.0 percentage points to 17.8 % (14.8 %)  ·  Operating earnings before depreciation and amortization (Ebitda) for continuing operations, excluding items affecting comparability, improved to SEK -12.7 (-18.5) million  ·  Operating earnings (Ebit) for continuing operations, excluding items affecting comparability, amounted to SEK -31.8 (-28.3) million   ·  Items

YIT acquired a plot in Warsaw, Poland

YIT Corporation Press Release October 20, 2016 at 9:00 a.m.YIT acquired a plot for an area development project in Warsaw, Poland. The acquired plot is located in Warsaw’s Białołęka district in the north eastern part of the city. The project consists of over 400 apartments and will be executed in 4 stages. Construction of the first phase is estimated to start in the fourth quarter of 2017. The plot is on an area of alteration of use and it is approximately 30,000 square metres. The plot acquisition supports YIT’s strategic target to grow business in the CEE countries. YIT started its

Boliden’s Q3: Strong earnings and high mine production

Boliden’s third quarter was primarily characterised by improvements in metal prices and high production in Mines. Revenues for the period totalled SEK 9,733 m (9,764) and the operating profit, excluding revaluation of process inventory, improved to SEK 1,318 m (1,055). The free cash flow was negatively affected by higher stock levels and totalled SEK 91 m (953).“Higher zinc prices, coupled with high production in our mines, yielded the strongest profit since 2011. It’s particularly pleasing to see the strong results by the Tara and Kevitsa mines, and Garpenberg continued the strong

There are no items matching the current filter
There are no more items matching the current filter
Back to top